lHeim_B

Tau22D phosphorylation.

AI Overview (Google's Gemini, March 26, 2026)

Yes, multiple phosphate (PO4) molecules can bind within the same functional regions or "pockets" of the tau protein, particularly in cases of hyperphosphorylation associated with Alzheimer’s disease.

Clustered Phosphorylation Sites: Tau is an intrinsically disordered protein (IDP) with about 85 potential phosphorylation sites. These sites are heavily clustered in the proline-rich region (residues 172-251) and the C-terminal tail (residues 368-441), which flank the microtubule-binding repeats. This high density means multiple phosphate groups often populate these regions simultaneously.
Binding Pocket Overlap: In the pathological, "hyperphosphorylated" state, the balance of kinases and phosphatases is disrupted, leading to the accumulation of many phosphate groups on a single tau molecule.
Specific Examples: Research shows that in Alzheimer’s diseased brains, hyperphosphorylated tau often has 5–9 phosphorylation sites modified, compared to only 2–3 in healthy adults.
Effect of Multiple Phosphates: The binding of multiple phosphates acts cumulatively. As more phosphate groups bind to tau, they remove the positive charge of the microtubule-binding region (MTBR), causing the tau protein to lose its affinity for microtubules, leading to aggregation.
Cooperative Binding: Phosphorylation at one site can sometimes prime or enhance phosphorylation at nearby sites within the same binding domain, facilitating the clustering of multiple phosphates.

In summary, the high concentration of potential sites in specific domains makes it likely that multiple phosphate groups reside in the same or closely positioned areas, directly causing the conformational changes that lead to pathology.

Order of binding	Receptor	Ligand	Affinity	Pocket ID	Residues that formed the binding pocket	Presence of SER, THR, TYR
1	Tau22D	PO4	-2.901	receptor_Tau22D_3	GLN-605 SER-606 CYS-608 GLY-609 SER-610 LYS-611 ASP-612	SER-606 SER-610
2	Tau22D	PO4	-2.83	receptor_Tau22D_11	VAL-667 GLN-668 SER-669 ILE-671 GLY-672 SER-673 LEU-674 ASP-675	SER-669 SER-673
3	Tau22D	PO4	-2.664	receptor_Tau22D_16	VAL-635 THR-636 SER-637 CYS-639 GLY-640 SER-641 LEU-642	THR-636 SER-637 SER-641
4	Tau22D	PO4	-2.696	receptor_Tau22D_3	GLN-605 SER-606 CYS-608 GLY-609 SER-610 LYS-611 ASP-612	SER-606 SER-610
5	Tau22D	PO4	-2.725	receptor_Tau22D_3	GLN-605 SER-606 CYS-608 GLY-609 SER-610 LYS-611 ASP-612	SER-606 SER-610
6	Tau22D	PO4	-2.52	receptor_Tau22D_11	VAL-667 GLN-668 SER-669 ILE-671 GLY-672 SER-673 LEU-674 ASP-675	SER-669 SER-673
7	Tau22D	PO4	-2.646	receptor_Tau22D_11	VAL-667 GLN-668 SER-669 ILE-671 GLY-672 SER-673 LEU-674 ASP-675	SER-669 SER-673
8	Tau22D	PO4	-2.446	receptor_Tau22D_4	VAL-269 ASP-270 PHE-271 LEU-272 SER-273	SER-273
9	Tau22D	PO4	-2.422	receptor_Tau22D_11	VAL-667 GLN-668 SER-669 ILE-671 GLY-672 SER-673 LEU-674 ASP-675	SER-669 SER-673